Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanostart AG making preparations for ADR trading in the United States

Abstract:
* ADR program with Bank of New York Mellon now active
* Commencement of trading imminent
* Focus on US capital market

Nanostart AG making preparations for ADR trading in the United States

Frankfurt am Main | Posted on October 1st, 2010

Nanostart AG is making preparations for ADR trading in the United States, which is scheduled to begin in October. Bank of New York Mellon (BNYM), one of the world's largest depositary banks, is providing active support during the process. Entry into the US capital market will accommodate growing interest in Nanostart on Wall Street. BNY Mellon has already initiated an ADR program for Nanostart. The next step will be the commencement of Nanostart ADR trading on the OTCQX market within the next few weeks.

ADRs (American Depositary Receipts) are certificates issued by a US bank that securitize ownership of stocks in a company. ADRs are traded as shares of the company in the United States.

Depositary bank for the Nanostart ADRs is Bank of New York Mellon, which employs over 40,000 people in 36 countries and reports assets of nearly 1.0 billion US dollars. Trading center for Nanostart ADRs is anticipated to be the OTCQX market.

The young and emergent OTCQX market provides US investors with a trading platform that allows convenient access to foreign companies and ensures transparent trading as well as assurance of comprehensive information. In addition, companies traded there are not subject to the high costs associated with a listing on other American markets. OTCQX is now the home of numerous international corporations, including many DAX-listed companies such as Adidas, Allianz, and BASF.

"We look forward to helping Nanostart unlock the investment potential of the US investor community," said Michael Cole-Fontayn, chief executive officer of BNY Mellon's Depositary Receipts business. "Senior executives at Nanostart have been highly collaborative in their approach to accessing the US capital markets and we believe this will translate well to potential investors. As the world's leading depositary, BNY Mellon will utilize its many resources to develop a mutually beneficial partnership between our respective organizations."

The Nanostart ADR program is described as a sponsored ADR Level 1 program. Ten Nanostart ADRs correspond to one Nanostart share. ADRs are denominated in US dollars. With an annual volume of approximately 18 billion dollars, the US capital market is by far the largest capital market in the world.

The ADRs are not offered by Nanostart AG. ADRs are not offered publicly in Germany.

Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the "Entry Standard" segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia or Japan.

####

For more information, please click here

Contacts:
Media contact:
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestraße 26-28
D-60313 Frankfurt am Main
Tel: +49 69-21 93 96 111
Fax: +49 69-21 93 96 122

Copyright © Nanostart AG

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New non-invasive method can detect Alzheimer's disease early: MRI probe technology shows brain toxins in living animals for first time December 22nd, 2014

Piezoelectricity in a 2-D semiconductor: Berkeley Lab researchers discovery of piezoelectricty in molybdenum disulfide holds promise for future MEMS December 22nd, 2014

Quantum physics just got less complicated December 22nd, 2014

Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014

Investments/IPO's/Splits

Pixelligent Closes $5.5 Million in Funding: Capital Will Be Used to Support Global Customer Growth December 12th, 2014

Nanometrics Announces Upcoming Investor Events November 19th, 2014

Eight19 secures £1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014

Arrowhead to Present at Upcoming Conferences November 15th, 2014

Announcements

New non-invasive method can detect Alzheimer's disease early: MRI probe technology shows brain toxins in living animals for first time December 22nd, 2014

Piezoelectricity in a 2-D semiconductor: Berkeley Lab researchers discovery of piezoelectricty in molybdenum disulfide holds promise for future MEMS December 22nd, 2014

Quantum physics just got less complicated December 22nd, 2014

Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014

Financial Reports

Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014

Harris & Harris Group to Host Conference Call on Third Quarter 2014 Financial Results on November 12, 2014 November 3rd, 2014

Aspen Aerogels, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 October 17th, 2014

Nanometrics to Announce Third Quarter Financial Results on October 28, 2014 October 8th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE